These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2472516)
21. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats. Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654 [TBL] [Abstract][Full Text] [Related]
22. Influence of long-term arotinolol treatment on myocardial mechanics and ventricular myosin isoenzymes in spontaneously hypertensive rats. Takeda N; Ohkubo T; Iwai T; Tanamura A; Nagano M Arch Int Pharmacodyn Ther; 1990; 305():63-8. PubMed ID: 1700686 [TBL] [Abstract][Full Text] [Related]
23. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Michel JB; Lattion AL; Salzmann JL; Cerol ML; Philippe M; Camilleri JP; Corvol P Circ Res; 1988 Apr; 62(4):641-50. PubMed ID: 2964944 [TBL] [Abstract][Full Text] [Related]
24. Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors. Brodde OE; Adamczyk M; Busch F; Bossaller C; Duske E; Fleck E; Götze S; Auch-Schwelk W J Am Coll Cardiol; 1995 Mar; 25(3):761-7. PubMed ID: 7860926 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of antihypertensive drug therapy on arterial compliance. Resnick LM; Lester MH Am J Hypertens; 2002 Dec; 15(12):1096-100. PubMed ID: 12460707 [TBL] [Abstract][Full Text] [Related]
29. Reduction in left ventricular mass in normotensive and spontaneously hypertensive rats given enalapril. Mooser V; Casley D; Trinder D; Paxton DL; Johnston CI Clin Exp Pharmacol Physiol; 1991 May; 18(5):341-4. PubMed ID: 1829664 [TBL] [Abstract][Full Text] [Related]
30. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties. Cambridge D; Whiting MV; Allan G Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacology of a new antihypertensive agent, metazosin (Kenosin)]. Trcka V; König J; Mácová S; Smíd M; Helfert I; Votavová M; Remesová J; Nezádalová E Cesk Farm; 1990 Jul; 39(6):266-74. PubMed ID: 1981860 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic mechanism of ventricular hypertrophy in hypertension. Chen HI Chin J Physiol; 2012 Dec; 55(6):369-79. PubMed ID: 23286444 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. Nemoto S; Hamawaki M; De Freitas G; Carabello BA J Am Coll Cardiol; 2002 Jul; 40(1):149-54. PubMed ID: 12103269 [TBL] [Abstract][Full Text] [Related]
34. Acute hemodynamic effects of combined inhibition of neutral endopeptidase and angiotensin converting enzyme in spontaneously hypertensive rats. Pham I; Lévy B; Fournié-Zaluski MC; Poitevin P; Roques BP; Michel JB Fundam Clin Pharmacol; 1995; 9(2):153-60. PubMed ID: 7628828 [TBL] [Abstract][Full Text] [Related]
35. Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats. Kohlmann O; Bresnahan M; Gavras H Hypertension; 1984; 6(2 Pt 2):I1-6. PubMed ID: 6327520 [TBL] [Abstract][Full Text] [Related]
36. Haemodynamic Responses to Selective Vagal Nerve Stimulation under Enalapril Medication in Rats. Gierthmuehlen M; Stieglitz T; Zentner J; Plachta DT PLoS One; 2016; 11(1):e0147045. PubMed ID: 26766419 [TBL] [Abstract][Full Text] [Related]
37. Effects of ACE inhibition and beta-blockade on collagen remodelling in the heart of Bio 14.6 hamsters. Mansoor AM; Honda M; Kuramochi T; Tanaka K; Morioka S; Takabatake T Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):43-9. PubMed ID: 8713495 [TBL] [Abstract][Full Text] [Related]
38. BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties. Allan G; Cambridge D; Hardy GW; Follenfant MJ Br J Pharmacol; 1987 Mar; 90(3):609-15. PubMed ID: 2882805 [TBL] [Abstract][Full Text] [Related]
39. Chronic treatment with angiotensin-converting enzyme inhibitor increases cardiac fibrosis in young rats submitted to early ovarian failure. Dutra SGV; Felix ACS; Gastaldi AC; De Paula Facioli T; Vieira S; De Souza HCD Auton Neurosci; 2017 Sep; 206():28-34. PubMed ID: 28712539 [TBL] [Abstract][Full Text] [Related]
40. BW A575C: pharmacological profile in vivo of a novel angiotensin converting enzyme inhibitor and beta-blocker. Cambridge D; Allan G; Hardy GW; Follenfant MJ; Ford A; Oliver PL J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S64-8. PubMed ID: 2454371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]